Cannabidiol and Alcohol Use Disorder Phenotypes
Key facts
- Who runs it
- University of Colorado, Denver
- Where
- Aurora, United StatesSee the site
- Trial code
- Status
- Recruiting
- Phase
- Phase 2
- People taking part
- 150 people, planned
- Started
- 21 Apr 2026
- Expected to end
- 31 Aug 2029
- Type of study
- Interventional, 3 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Full-Spectrum Cannabidiol (CBD)
- Broad-Spectrum Cannabidiol (CBD)
- Placebo
- Record updated
- 16 September 2026
Who can take part
- Age
- 21 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (9)Hide the full registry criteria
Who can take part
- Age 21-65
- Have used CBD and cannabis at least once in the last year
- Regularly drink alcohol
- Able to provide informed consent and attend in-person study visits
Who cannot take part
- Current use of medications known to have major interaction with Epidiolex, Marinol, or alcohol
- Current use of antiepileptic medication or any psychotropic medication besides antidepressants
- Medical conditions that contraindicates the use of CBD or alcohol
- Current medical conditions that may require intensive care during the study period; Not everyone will qualify to be in the study. Other inclusion and exclusion criteria will be evaluated by the study team
- Pregnant, nursing, or planning a pregnancy
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Alcohol use disorder
This trial is currently available in United States.
- University of Colorado School of Medicine. Anschutz Medical CampusAurora, United StatesContact: Hollis C Karoly, PhDTaking people
About the trial
What the trial wants to find out
The goal of this study is to learn how CBD affects drinking in people who drink alcohol regularly. Researchers want to see if CBD can help people drink less and reduce problems related to alcohol use.
The 3 groups in the trial
- Full-Spectrum CBDTreatment being tested
Subjects will take 200 mg of full-spectrum CBD (\[fsCBD\] CBD that contains \<0.3% THC) daily for 8 weeks. The total dose is split into a morning and evening dose, such that participants in the fsCBD condition will take approximately 100mg fsCBD in the morning (2 capsules) and 100mg fsCBD in the evening (2 capsules).
Treatment: Full-Spectrum Cannabidiol (CBD)
- Broad- Spectrum CBDTreatment being tested
Subjects will take 200 mg of broad-spectrum CBD (\[bsCBD\] CBD that contains no THC) daily for 8 weeks. The total dose is split into a morning and evening dose, such that participants in the bsCBD condition will take approximately 100mg bsCBD in the morning (2 capsules) and 100mg bsCBD in the evening (2 capsules).
Treatment: Broad-Spectrum Cannabidiol (CBD)
- PlaceboPlacebo, for comparison
Subjects will take a matching placebo solution (100% Hemp Seed Oil) daily for 8 weeks. The total dose is split into a morning and evening dose, such that participants in the condition will take approximately 100mg hemp seed oil in the morning (2 capsules) and 100mg hemp seed oil in the evening (2 capsules).
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effects of Full-spectrum Cannabidiol on Alcohol Consumption and Alcohol Use Disorder Phenotypes: Implications for Precision Medicine
- Criteria questions
- Built from NCT07279558, who can take part
- Record updated
- 16 September 2026